Table 4.
Diagnostic approach | Criteria |
AUC (95%CI) |
||
1 yr | 3 yr | 5 yr | ||
Preoperative | Milan1 | 0.814 | 0.804 | 0.799 |
imaging | (0.754, 0.873) | (0.750, 0.858) | (0.747, 0.851) | |
UCSF2 | 0.812 | 0.800 | 0.793 | |
(0.754, 0.871) | (0.747, 0.853) | (0.741, 0.844) | ||
NCCK3 | 0.810 | 0.806 | 0.802 | |
(0.753, 0.867) | (0.755, 0.857) | (0.753, 0.852) | ||
Explant pathology | Milan4 | 0.824 | 0.815 | 0.807 |
(0.767, 0.880) | (0.764, 0.866) | (0.757, 0.856) | ||
UCSF5 | 0.819 | 0.811 | 0.803 | |
(0.761, 0.877) | (0.759, 0.863) | (0.752, 0.853) | ||
NCCK6 | 0.823 | 0.817 | 0.810 | |
(0.769, 0.878) | (0.767, 0.866) | (0.762, 0.857) |
Adjusted by PET, X, Y and Z;
By PET, X and Y;
By maximum tumor size, X, Y, and Z;
By PET, total tumor size, X and Y;
By PET, X, Y, and Z;
By total tumor size, X, Y, and Z. X: Microvascular invasion; Y: Major vessel invasion; Z: Intrahepatic metastasis; AUC: Area under the curves; UCSF: University of California, San Francisco; PET: Positron emission tomography; NCCK: National Cancer Center Korea; 95%CI and P value were calculated by Cox PH regression analyses adjusted by the following covariates for each criteria.